These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 32622636)

  • 21. Anterior segment parameters in Behçet's patients with ocular involvement.
    Ozbek-Uzman S; Karatas Sungur G; Yalniz-Akkaya Z; Orman G; Burcu A; Ornek F
    Int Ophthalmol; 2020 Jun; 40(6):1387-1395. PubMed ID: 32067151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Optic neuropathy in Behçet's disease: a series of 18 patients].
    Frigui M; Kechaou M; Jemal M; Ben Zina Z; Feki J; Bahloul Z
    Rev Med Interne; 2009 Jun; 30(6):486-91. PubMed ID: 19375828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Behçet's disease.
    Bonfioli AA; Orefice F
    Semin Ophthalmol; 2005; 20(3):199-206. PubMed ID: 16282155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uveitis in juvenile Behçet's disease: clinical course and visual outcome compared with adult patients.
    Kramer M; Amer R; Mukamel M; Snir M; Jaouni T; Friling R
    Eye (Lond); 2009 Nov; 23(11):2034-41. PubMed ID: 19151650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ocular Manifestations and Visual Outcomes of Behçet's Uveitis in a Thai population.
    Pathanapitoon K; Kunavisarut P; Saravuttikul FA; Rothova A
    Ocul Immunol Inflamm; 2019; 27(1):2-6. PubMed ID: 29020486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Characteristics of ocular involvement in Behçet disease in Tunisia: Monocentric study and review of literature].
    Ajili F; Bellakhal S; Ben Abdelhafidh N; Mrabet A; Zouari B; Maalej A; Louzir B; Laabidi J; Othmani S
    Pathol Biol (Paris); 2015 Apr; 63(2):85-90. PubMed ID: 25434793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.
    Tugal-Tutkun I; Mudun A; Urgancioglu M; Kamali S; Kasapoglu E; Inanc M; Gül A
    Arthritis Rheum; 2005 Aug; 52(8):2478-84. PubMed ID: 16052571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ocular Behçet].
    Alami A; Kriet M; Reda K; Laktaoui A; Oubaaz A
    Pan Afr Med J; 2017; 26():237. PubMed ID: 28690751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ophthalmologic manifestations of Behçet's disease, about 33 cases].
    Andaloussi IB; Alami B; Abdellaoui M; Bhallil S; Bono W; Tahri H
    Pan Afr Med J; 2012; 13():83. PubMed ID: 23396991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis.
    Kötter I; Zierhut M; Eckstein AK; Vonthein R; Ness T; Günaydin I; Grimbacher B; Blaschke S; Meyer-Riemann W; Peter HH; Stübiger N
    Br J Ophthalmol; 2003 Apr; 87(4):423-31. PubMed ID: 12642304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical features of chinese patients with Behçet's disease.
    Yang P; Fang W; Meng Q; Ren Y; Xing L; Kijlstra A
    Ophthalmology; 2008 Feb; 115(2):312-318.e4. PubMed ID: 17692378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet's disease-related uveitis: a multicenter retrospective observational study.
    Fabiani C; Vitale A; Emmi G; Lopalco G; Vannozzi L; Guerriero S; Gentileschi S; Bacherini D; Franceschini R; Frediani B; Galeazzi M; Iannone F; Tosi GM; Cantarini L
    Clin Rheumatol; 2017 Jan; 36(1):191-197. PubMed ID: 27981463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ocular Manifestations, Conventional Fundus Fluorescein Angiographic Findings, and Relationship Between Angiographic Findings and Visual Acuity in Behçet's Disease.
    Bazvand F; Zarei M; Ebrahimiadib N; Karkhaneh R; Davoudi S; Soleimanzadeh M; Sharifian E; Roohipoor R; Modjtahedi BS
    Semin Ophthalmol; 2017; 32(6):764-771. PubMed ID: 27715380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of biological therapy compared to synthetic immunomodulatory drugs or placebo in the treatment of Behçet's disease associated uveitis: a systematic review.
    Urruticoechea-Arana A; Cobo-Ibáñez T; Villaverde-García V; Santos Gómez M; Loza E; Vargas-Osorio K; Fariñas Padrón L; Diaz-Gonzalez F; Calvo-Río V; Blanco R
    Rheumatol Int; 2019 Jan; 39(1):47-58. PubMed ID: 30421105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visual aspects of Behçet's disease.
    Kansu T; Kadayifcilar S
    Curr Neurol Neurosci Rep; 2005 Sep; 5(5):382-8. PubMed ID: 16131421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behçet's disease uveitis: is there a need for new emerging drugs?
    Tugal-Tutkun I; Çakar Özdal P
    Expert Opin Emerg Drugs; 2020 Dec; 25(4):531-547. PubMed ID: 33147420
    [No Abstract]   [Full Text] [Related]  

  • 37. Ocular manifestations of Behçet's disease in Jordanian patients.
    Abu-Ameerh MA; Mohammed SF; Mohammad MT; Ababneh OH; Al-Bdour MD
    Saudi J Ophthalmol; 2013 Oct; 27(4):247-51. PubMed ID: 24371419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frosted branch angiitis and cerebral venous sinus thrombosis as an initial onset of neuro-Behçet's disease: a case report and review of the literature.
    Ferreira BFA; Rodriguez EEC; Prado LLD; Gonçalves CR; Hirata CE; Yamamoto JH
    J Med Case Rep; 2017 Apr; 11(1):104. PubMed ID: 28410605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lessons of the month 2: A case of Behçet's disease: 70% have ophthalmic involvement.
    Auluck I; Karimi A; Taylor S
    Clin Med (Lond); 2019 Nov; 19(6):519-522. PubMed ID: 31732597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet's disease: multicentre retrospective study.
    Atienza-Mateo B; Calvo-Río V; Beltrán E; Martínez-Costa L; Valls-Pascual E; Hernández-Garfella M; Atanes A; Cordero-Coma M; Miquel Nolla J; Carrasco-Cubero C; Loricera J; González-Vela MC; Vegas-Revenga N; Fernández-Díaz C; Demetrio-Pablo R; Domínguez-Casas LC; Luis Martín-Varillas J; Palmou-Fontana N; Hernández JL; González-Gay MÁ; Blanco R
    Rheumatology (Oxford); 2018 May; 57(5):856-864. PubMed ID: 29471416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.